— Know what they know.
Not Investment Advice

CDXC NASDAQ

ChromaDex Corporation
1W: +9.2% 1M: -21.7% 3M: +16.7% 1Y: +50.1% 3Y: +148.6% 5Y: +76.4%
$7.87
Last traded 2025-04-14 — delisted
NASDAQ · Healthcare · Biotechnology · $611.9M mcap · 51M float · 1.59% daily turnover · Short 36% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-100.0% YoY
$19M
Net Income
+32.1% YoY
$34M
Free Cash Flow
+71.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE30.4%
ROA21.3%
ROIC85.0%

Valuation

P/E15.7
P/B3.6
EV/EBITDA33.0

Leverage

Debt/Equity0.04
Current Ratio4.86
Interest Cov.0.0x

Quality Scores

Piotroski F6/9
Altman Z9.40
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms